Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2012 Oct 23

PMID 23086948

Citations 102

Authors

D James Surmeier

Paul T Schumacker

Affiliations

Soon will be listed here.

Abstract

The most distinguishing feature of neurons is their capacity for regenerative electrical activity. This activity imposes a significant mitochondrial burden, especially in neurons that are autonomously active, have broad action potentials, and exhibit prominent Ca(2+) entry. Many of the genetic mutations and toxins associated with Parkinson's disease compromise mitochondrial function, providing a mechanistic explanation for the pattern of neuronal pathology in this disease. Because much of the neuronal mitochondrial burden can be traced to L-type voltage-dependent channels (channels for which there are brain-penetrant antagonists approved for human use), a neuroprotective strategy to reduce this burden is available.

Citing Articles

Comparative mapping of single-cell transcriptomic landscapes in neurodegenerative diseases.

Shwab E, Man Z, Gingerich D, Gamache J, Garrett M, Serrano G bioRxiv. 2025; .

PMID: 39764045 PMC: 11702568. DOI: 10.1101/2024.12.13.628436.

Advancements in Targeting Ion Channels for the Treatment of Neurodegenerative Diseases.

Li Y, Fu J, Wang H Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598374 PMC: 11597607. DOI: 10.3390/ph17111462.

Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.

Currim F, Tanwar R, Brown-Leung J, Paranjape N, Liu J, Sanders L Neurotoxicology. 2024; 103:266-287.

PMID: 38964509 PMC: 11288778. DOI: 10.1016/j.neuro.2024.06.016.

Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates.

Balzano T, Del Rey N, Esteban-Garcia N, Reinares-Sebastian A, Pineda-Pardo J, Trigo-Damas I NPJ Parkinsons Dis. 2024; 10(1):118.

PMID: 38886348 PMC: 11183116. DOI: 10.1038/s41531-024-00735-w.

Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration.

Rademacher K, Doric Z, Haddad D, Mamaligas A, Liao S, Creed R bioRxiv. 2024; .

PMID: 38645054 PMC: 11030348. DOI: 10.1101/2024.04.05.588321.

References

Hirsch E, Hunot S . Neuroinflammation in Parkinson's disease: a target for neuroprotection?. Lancet Neurol. 2009; 8(4):382-97. DOI: 10.1016/S1474-4422(09)70062-6. View

Chan J, Chan S . Passive electrical properties of spontaneously active neurons in the nucleus reticularis gigantocellularis of the cat. Neurosci Lett. 1989; 97(1-2):169-74. DOI: 10.1016/0304-3940(89)90158-4. View

Ping H, Shepard P . Apamin-sensitive Ca(2+)-activated K+ channels regulate pacemaker activity in nigral dopamine neurons. Neuroreport. 1996; 7(3):809-14. DOI: 10.1097/00001756-199602290-00031. View

Pignatelli A, Kobayashi K, Okano H, Belluzzi O . Functional properties of dopaminergic neurones in the mouse olfactory bulb. J Physiol. 2005; 564(Pt 2):501-14. PMC: 1464431. DOI: 10.1113/jphysiol.2005.084632. View

Lee I, Bender E, Arnold S, KADENBACH B . New control of mitochondrial membrane potential and ROS formation--a hypothesis. Biol Chem. 2002; 382(12):1629-36. DOI: 10.1515/BC.2001.198. View

Przedborski S, Tieu K, Perier C, Vila M . MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J Bioenerg Biomembr. 2004; 36(4):375-9. DOI: 10.1023/B:JOBB.0000041771.66775.d5. View

German D, Manaye K, Sonsalla P, Brooks B . Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann N Y Acad Sci. 1992; 648:42-62. DOI: 10.1111/j.1749-6632.1992.tb24523.x. View

Decuypere J, Bultynck G, Parys J . A dual role for Ca(2+) in autophagy regulation. Cell Calcium. 2011; 50(3):242-50. DOI: 10.1016/j.ceca.2011.04.001. View

Khaliq Z, Bean B . Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances. J Neurosci. 2010; 30(21):7401-13. PMC: 2892804. DOI: 10.1523/JNEUROSCI.0143-10.2010. View

10.

Burlhis T, Aghajanian G . Pacemaker potentials of serotonergic dorsal raphe neurons: contribution of a low-threshold Ca2+ conductance. Synapse. 1987; 1(6):582-8. DOI: 10.1002/syn.890010611. View

11.

Bender A, Krishnan K, Morris C, Taylor G, Reeve A, Perry R . High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006; 38(5):515-7. DOI: 10.1038/ng1769. View

12.

Lloyd-Evans E, Platt F . Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases. Cell Calcium. 2011; 50(2):200-5. DOI: 10.1016/j.ceca.2011.03.010. View

13.

Fahn S . Does levodopa slow or hasten the rate of progression of Parkinson's disease?. J Neurol. 2005; 252 Suppl 4:IV37-IV42. DOI: 10.1007/s00415-005-4008-5. View

14.

Baysal B, Ferrell R, Willett-Brozick J, Lawrence E, Myssiorek D, Bosch A . Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000; 287(5454):848-51. DOI: 10.1126/science.287.5454.848. View

15.

Augustine G, Santamaria F, Tanaka K . Local calcium signaling in neurons. Neuron. 2003; 40(2):331-46. DOI: 10.1016/s0896-6273(03)00639-1. View

16.

Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K . Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004; 318(1):121-34. DOI: 10.1007/s00441-004-0956-9. View

17.

German D, Manaye K, White 3rd C, Woodward D, McIntire D, Smith W . Disease-specific patterns of locus coeruleus cell loss. Ann Neurol. 1992; 32(5):667-76. DOI: 10.1002/ana.410320510. View

18.

Lee C, Tepper J . Morphological and physiological properties of parvalbumin- and calretinin-containing gamma-aminobutyric acidergic neurons in the substantia nigra. J Comp Neurol. 2006; 500(5):958-72. DOI: 10.1002/cne.21220. View

19.

Clapham D . Calcium signaling. Cell. 2007; 131(6):1047-58. DOI: 10.1016/j.cell.2007.11.028. View

20.

Beal M . Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 1995; 38(3):357-66. DOI: 10.1002/ana.410380304. View